Vimarsana
Biggest News Aggregation in the World

Page 50 - Roche Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Diagnostics Today - Breaking & Trending Today

Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Vimarsana News

Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend

While reporting financial results for the first quarter on Monday, healthcare company Viatris Inc. (VTRS) reaffirmed its total revenue guidance for the full-year 2023.

Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk - Vimarsana News

Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk

The US Food and Drug Administration issued a warning on Friday to consumers and health providers to discontinue using and discard recalled Pilot COVID-19 At-Home Tests made by SD Biosensor,

Source: kdrv.com
Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk - Vimarsana News

Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk

SD Biosensor, the manufacturer of the at-home tests, recalls the tests after "significant concerns" of bacterial contamination.

Source: komu.com
Do not use: FDA issues warning about recalled COVID-19 tests due to bacterial contamination - Vimarsana News

Do not use: FDA issues warning about recalled COVID-19 tests due to bacterial contamination

(WHTM) -- The U.S. Food and Drug Administration issued a safety warning against the use of some recalled at-home COVID-19 tests. The FDA says SD Biosensor Inc. Pilot COVID-19 at-home tests, which are distributed by Roche Diagnostics, have been recalled over concerns of bacterial contamination in the

Source: fox969.com
Some Pilot COVID-19 at-home tests recalled by FDA over bacteria risk - Vimarsana News

Some Pilot COVID-19 at-home tests recalled by FDA over bacteria risk

Some 500,000 tests were distributed to CVS Health, as well as about 16,000 tests to Amazon, the FDA said.

Source: wmur.com